Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
SETH SANDESHDirector · Chief Executive Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 33,333 | $0.00 Strike: $23.49 | $0.00 |
DisclosureSEC source: 0001213900-25-028226 · ownership.xml · derivative · entry 3 SETH SANDESH · CIK 0001566175 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,333 shares Expires 2028-07-13 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
SETH SANDESHDirector · Chief Executive Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $41.70 | $0.00 |
DisclosureSEC source: 0001213900-25-028226 · ownership.xml · derivative · entry 2 SETH SANDESH · CIK 0001566175 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2027-03-14 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
SETH SANDESHDirector · Chief Executive Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 16,666 | $0.00 Strike: $59.70 | $0.00 |
DisclosureSEC source: 0001213900-25-028226 · ownership.xml · derivative · entry 1 SETH SANDESH · CIK 0001566175 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,666 shares Expires 2026-04-15 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, of the Issuer effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
O'Loughlin SteveChief Financial Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 253,123 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001213900-25-028225 · ownership.xml · derivative · entry 9 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 253,123 shares Expires 2033-12-28 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
O'Loughlin SteveChief Financial Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 256,438 | $0.00 Strike: $4.96 | $0.00 |
DisclosureSEC source: 0001213900-25-028225 · ownership.xml · derivative · entry 8 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 256,438 shares Expires 2032-07-01 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
O'Loughlin SteveChief Financial Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 107,463 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001213900-25-028225 · ownership.xml · derivative · entry 7 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 107,463 shares Expires 2031-09-01 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
O'Loughlin SteveChief Financial Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 59,066 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001213900-25-028225 · ownership.xml · derivative · entry 6 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,066 shares Expires 2030-08-12 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
O'Loughlin SteveChief Financial Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 13,333 | $0.00 Strike: $6.96 | $0.00 |
DisclosureSEC source: 0001213900-25-028225 · ownership.xml · derivative · entry 5 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,333 shares Expires 2029-07-12 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
O'Loughlin SteveChief Financial Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 8,833 | $0.00 Strike: $23.49 | $0.00 |
DisclosureSEC source: 0001213900-25-028225 · ownership.xml · derivative · entry 4 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,833 shares Expires 2028-07-13 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
O'Loughlin SteveChief Financial Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 3,333 | $0.00 Strike: $41.70 | $0.00 |
DisclosureSEC source: 0001213900-25-028225 · ownership.xml · derivative · entry 3 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,333 shares Expires 2027-03-14 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
O'Loughlin SteveChief Financial Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 1,666 | $0.00 Strike: $59.70 | $0.00 |
DisclosureSEC source: 0001213900-25-028225 · ownership.xml · derivative · entry 2 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,666 shares Expires 2026-04-14 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| March 31, 2025 Filed Apr 2, 2025 22:20 UTC |
O'Loughlin SteveChief Financial Officer
|
Disposition to issuerStock Option (Right to Buy) · Derivative | 3,333 | $0.00 Strike: $53.70 | $0.00 |
DisclosureSEC source: 0001213900-25-028225 · ownership.xml · derivative · entry 1 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,333 shares Expires 2025-10-01 F1 · derivative.exercise_price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · price: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. F1 · derivative.exercise_date: Pursuant to that certain Option Cancellation and Release Agreement, dated as of March 31, 2025, by and between the Issuer and the Reporting Person, the Reporting Person agreed to cancel the reported stock options to purchase shares of common stock, par value $0.001 per share, effective March 31, 2025, in exchange for nominal consideration. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 17:12 UTC |
Almenoff June SherieDirector
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001213900-24-094632 · ownership.xml · derivative · entry 1 Almenoff June Sherie · CIK 0001492647 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2034-11-01 F1 · derivative.exercise_price: Represents a grant of stock options granted in connection with the Reporting Person's appointment as a director of the Issuer's Board of Directors. The exercise price represents the closing stock price of the Issuer's common stock, par value $0.001 per share, on November 1, 2024, the date of the grant. F2 · derivative.exercise_date: The options shall vest as follows: (i) 28% of the options shall vest on the 12-month anniversary of the date of grant, and (ii) 2% of the options shall vest each month from the date of grant, until fully vested. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 17:18 UTC |
Shetty AjitDirector
|
GrantStock Option (Right to Buy) · Derivative | 70,311 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001213900-23-100068 · ownership.xml · derivative · entry 1 Shetty Ajit · CIK 0001667471 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,311 Underlying: Common Stock · 70,311 shares Expires 2033-12-28 F1 · derivative.exercise_price: This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:23 UTC |
Steinhart Richard IDirector
|
GrantStock Option (Right to Buy) · Derivative | 70,311 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001213900-23-100086 · ownership.xml · derivative · entry 1 Steinhart Richard I · CIK 0001293789 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,311 Underlying: Common Stock · 70,311 shares Expires 2033-12-28 F1 · derivative.exercise_price: This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:24 UTC |
Nicholson, C. DavidDirector
|
GrantStock Option (Right to Buy) · Derivative | 70,311 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001213900-23-100091 · ownership.xml · derivative · entry 1 Nicholson, C. David · CIK 0001636168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,311 Underlying: Common Stock · 70,311 shares Expires 2033-12-28 F1 · derivative.exercise_price: This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:20 UTC |
O'Loughlin SteveChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 253,123 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001213900-23-100077 · ownership.xml · derivative · entry 1 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,123 Underlying: Common Stock · 253,123 shares Expires 2033-12-28 F1 · derivative.exercise_price: This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:17 UTC |
SETH SANDESHDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 984,367 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001213900-23-100063 · ownership.xml · derivative · entry 1 SETH SANDESH · CIK 0001566175 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 984,367 Underlying: Common Stock · 984,367 shares Expires 2033-12-28 F1 · derivative.exercise_price: This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:15 UTC |
Chell Jeffrey W.Director
|
GrantStock Option (Right to Buy) · Derivative | 70,311 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001213900-23-100057 · ownership.xml · derivative · entry 1 Chell Jeffrey W. · CIK 0001738374 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,311 Underlying: Common Stock · 70,311 shares Expires 2033-12-28 F1 · derivative.exercise_price: This price represents the closing price of the Issuer's common stock on December 28, 2023, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Issuer's 2019 Stock Plan, 2% of the options will vest each month from the date of grant until fully vested. Read SEC document |
| August 17, 2022 Filed Aug 19, 2022 20:55 UTC |
SETH SANDESHDirector · Chief Executive Officer
|
GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-22-049737 · ownership.xml · nonDerivative · entry 1 SETH SANDESH · CIK 0001566175 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 305,381 Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 19:14 UTC |
Shetty AjitDirector
|
GrantStock Option (Right to Buy) · Derivative | 72,156 | $0.00 Strike: $4.96 | $0.00 |
DisclosureSEC source: 0001213900-22-036871 · ownership.xml · derivative · entry 1 Shetty Ajit · CIK 0001667471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,156 Underlying: Common Stock · 72,156 shares Expires 2032-07-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 23:16 UTC |
Steinhart Richard IDirector
|
GrantStock Option (Right to Buy) · Derivative | 72,156 | $0.00 Strike: $4.96 | $0.00 |
DisclosureSEC source: 0001213900-22-036873 · ownership.xml · derivative · entry 1 Steinhart Richard I · CIK 0001293789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,156 Underlying: Common Stock · 72,156 shares Expires 2032-07-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 23:19 UTC |
O'Loughlin SteveDirector · Chief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 256,438 | $0.00 Strike: $4.96 | $0.00 |
DisclosureSEC source: 0001213900-22-036877 · ownership.xml · derivative · entry 1 O'Loughlin Steve · CIK 0001615840 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 256,348 Underlying: Common Stock · 256,438 shares Expires 2032-07-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 23:17 UTC |
Nicholson, C. DavidDirector
|
GrantStock Option (Right to Buy) · Derivative | 72,156 | $0.00 Strike: $4.96 | $0.00 |
DisclosureSEC source: 0001213900-22-036875 · ownership.xml · derivative · entry 1 Nicholson, C. David · CIK 0001636168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,156 Underlying: Common Stock · 72,156 shares Expires 2032-07-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 23:13 UTC |
SETH SANDESHDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 827,366 | $0.00 Strike: $4.96 | $0.00 |
DisclosureSEC source: 0001213900-22-036868 · ownership.xml · derivative · entry 1 SETH SANDESH · CIK 0001566175 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 827,366 Underlying: Common Stock · 827,366 shares Expires 2032-07-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested. Read SEC document |
| July 01, 2022 Filed Jul 1, 2022 23:11 UTC |
Chell Jeffrey W.Director
|
GrantStock Option (Right to Buy) · Derivative | 72,156 | $0.00 Strike: $4.96 | $0.00 |
DisclosureSEC source: 0001213900-22-036866 · ownership.xml · derivative · entry 1 Chell Jeffrey W. · CIK 0001738374 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,156 Underlying: Common Stock · 72,156 shares Expires 2032-07-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on July 1, 2022, the date of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's 2019 Stock Plan, 2% of the options will vest each month from July 1, 2022 until fully vested. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 17:03 UTC |
Shetty AjitDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,351 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001213900-21-046685 · ownership.xml · derivative · entry 1 Shetty Ajit · CIK 0001667471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,351 Underlying: Common Stock · 18,351 shares Expires 2031-09-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:02 UTC |
Steinhart Richard IDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,351 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001213900-21-046683 · ownership.xml · derivative · entry 1 Steinhart Richard I · CIK 0001293789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,351 Underlying: Common Stock · 18,351 shares Expires 2031-09-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:05 UTC |
Chell Jeffrey W.Director
|
GrantStock Option (Right to Buy) · Derivative | 18,351 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001213900-21-046688 · ownership.xml · derivative · entry 1 Chell Jeffrey W. · CIK 0001738374 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,351 Underlying: Common Stock · 18,351 shares Expires 2031-09-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:04 UTC |
Berger Mark StanleyChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 67,164 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001213900-21-046687 · ownership.xml · derivative · entry 1 Berger Mark Stanley · CIK 0001700283 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,164 Underlying: Common Stock · 67,164 shares Expires 2031-09-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:02 UTC |
O'Loughlin SteveChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 107,463 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001213900-21-046684 · ownership.xml · derivative · entry 1 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,463 Underlying: Common Stock · 107,463 shares Expires 2031-09-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:01 UTC |
SETH SANDESHDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 310,182 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001213900-21-046682 · ownership.xml · derivative · entry 1 SETH SANDESH · CIK 0001566175 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 310,182 Underlying: Common Stock · 310,182 shares Expires 2031-09-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:00 UTC |
Nicholson, C. DavidDirector
|
GrantStock Option (Right to Buy) · Derivative | 18,351 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001213900-21-046679 · ownership.xml · derivative · entry 1 Nicholson, C. David · CIK 0001636168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,351 Underlying: Common Stock · 18,351 shares Expires 2031-09-01 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from September 1, 2021 until fully vested. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 17:03 UTC |
Shetty AjitDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,333 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001213900-20-022319 · ownership.xml · derivative · entry 1 Shetty Ajit · CIK 0001667471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,333 shares Expires 2030-08-12 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 21:03 UTC |
Steinhart Richard IDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,333 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001213900-20-022320 · ownership.xml · derivative · entry 1 Steinhart Richard I · CIK 0001293789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,333 shares Expires 2030-08-12 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 21:21 UTC |
O'Loughlin SteveChief Financial Officer
|
GrantStock Option (Right to Buy) · Derivative | 59,066 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001213900-20-022342 · ownership.xml · derivative · entry 1 O'Loughlin Steve · CIK 0001615840 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,066 Underlying: Common Stock · 59,066 shares Expires 2030-08-12 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 21:21 UTC |
SETH SANDESHDirector · Chief Executive Officer
|
GrantStock Option (Right to Buy) · Derivative | 139,062 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001213900-20-022341 · ownership.xml · derivative · entry 1 SETH SANDESH · CIK 0001566175 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,062 Underlying: Common Stock · 139,062 shares Expires 2030-08-12 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 21:17 UTC |
Berger Mark StanleyChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 46,667 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001213900-20-022337 · ownership.xml · derivative · entry 1 Berger Mark Stanley · CIK 0001700283 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,667 Underlying: Common Stock · 46,667 shares Expires 2030-08-12 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 21:18 UTC |
Chell Jeffrey W.Director
|
GrantStock Option (Right to Buy) · Derivative | 8,333 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001213900-20-022339 · ownership.xml · derivative · entry 1 Chell Jeffrey W. · CIK 0001738374 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,333 shares Expires 2030-08-12 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 21:03 UTC |
Ludwig Dale L.Chief Science & Tech. Officer
|
GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001213900-20-022314 · ownership.xml · derivative · entry 1 Ludwig Dale L. · CIK 0001727406 · Chief Science & Tech. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-08-12 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 21:02 UTC |
Nicholson, C. DavidDirector
|
GrantStock Option (Right to Buy) · Derivative | 8,333 | $0.00 Strike: $9.55 | $0.00 |
DisclosureSEC source: 0001213900-20-022313 · ownership.xml · derivative · entry 1 Nicholson, C. David · CIK 0001636168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,333 Underlying: Common Stock · 8,333 shares Expires 2030-08-12 F1 · derivative.exercise_price: This price represents the closing price of the Company's common stock on the date of the board of directors approval of the grant. F2 · derivative.exercise_date: Pursuant to the terms of the Company's Amended and Restated 2013 Stock Plan and 2019 Stock Plan, 2% of the options will vest each month from August 12, 2020 until fully vested. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 16:58 UTC |
Shetty AjitDirector
|
GrantOptions to purchase common stock · Derivative | 250,000 | $0.23 Strike: $0.23 | $58,000.00 |
DisclosureSEC source: 0001213900-19-012871 · ownership.xml · derivative · entry 1 Shetty Ajit · CIK 0001667471 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-07-12 F1 · derivative.exercise_date: Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 21:19 UTC |
Steinhart Richard IDirector
|
GrantOptions to purchase common stock · Derivative | 250,000 | $0.23 Strike: $0.23 | $58,000.00 |
DisclosureSEC source: 0001213900-19-012891 · ownership.xml · derivative · entry 1 Steinhart Richard I · CIK 0001293789 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-07-12 F1 · derivative.exercise_date: Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 21:16 UTC |
Chell Jeffrey W.Director
|
GrantOptions to purchase common stock · Derivative | 250,000 | $0.23 Strike: $0.23 | $58,000.00 |
DisclosureSEC source: 0001213900-19-012888 · ownership.xml · derivative · entry 1 Chell Jeffrey W. · CIK 0001738374 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-07-12 F1 · derivative.exercise_date: Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 21:13 UTC |
Ludwig Dale L.Chief Scientific Officer
|
GrantOptions to purchase common stock · Derivative | 400,000 | $0.23 Strike: $0.23 | $92,800.00 |
DisclosureSEC source: 0001213900-19-012884 · ownership.xml · derivative · entry 1 Ludwig Dale L. · CIK 0001727406 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2029-07-12 F1 · derivative.exercise_date: Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 21:10 UTC |
O'Loughlin StevePrincipal Financial Officer
|
GrantOptions to purchase common stock · Derivative | 400,000 | $0.23 Strike: $0.23 | $92,800.00 |
DisclosureSEC source: 0001213900-19-012881 · ownership.xml · derivative · entry 1 O'Loughlin Steve · CIK 0001615840 · Principal Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2029-07-12 F1 · derivative.exercise_date: Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 21:07 UTC |
Berger Mark StanleyChief Medical Officer
|
GrantOptions to purchase common stock · Derivative | 400,000 | $0.23 Strike: $0.23 | $92,800.00 |
DisclosureSEC source: 0001213900-19-012879 · ownership.xml · derivative · entry 1 Berger Mark Stanley · CIK 0001700283 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2029-07-12 F1 · derivative.exercise_date: Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:59 UTC |
Kapur AnilChief Commercial Officer
|
GrantOptions to purchase common stock · Derivative | 400,000 | $0.23 Strike: $0.23 | $92,800.00 |
DisclosureSEC source: 0001213900-19-012873 · ownership.xml · derivative · entry 1 Kapur Anil · CIK 0001730703 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2029-07-12 F1 · derivative.exercise_date: Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 21:02 UTC |
SETH SANDESHDirector · CEO
|
GrantOptions to purchase common stock · Derivative | 1,500,000 | $0.23 Strike: $0.23 | $348,000.00 |
DisclosureSEC source: 0001213900-19-012875 · ownership.xml · derivative · entry 1 SETH SANDESH · CIK 0001566175 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,500,000 Underlying: Common Stock · 1,500,000 shares Expires 2029-07-12 F1 · derivative.exercise_date: Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:55 UTC |
Nicholson, C. DavidDirector
|
GrantOptions to purchase common stock · Derivative | 250,000 | $0.23 Strike: $0.23 | $58,000.00 |
DisclosureSEC source: 0001213900-19-012869 · ownership.xml · derivative · entry 1 Nicholson, C. David · CIK 0001636168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250,000 Underlying: Common Stock · 250,000 shares Expires 2029-07-12 F1 · derivative.exercise_date: Pursuant to the terms of the company's Amended and Restated 2013 Stock Plan, 2% of the options vest each month from the date of grant. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.